cu ghk peptide GHK-Cu GHK-Cu 50mg | Skin &

Human clinical safety data for BPC-157 is very limited

You will choose a location when you schedule a consultation

BPC-157 is the standard example: preclinical work describes rapid plasma clearance, while the effects attributed to it in animal models involve angiogenic and fibroblast-migration pathways that continue after the peptide itself is gone

Who are the typical patients who present at our clinic

The consistently reported poor diagnosis and treatment experience encountered in UK Primary Care by people with a diagnosis, or symptomatic of, Pernicious Anaemia in the UK is well documented and reported on in research carried out and published by the Pernicious Anaemia Society